MiMedx Group Inc
✓ Verified ManufacturerAbout
MiMedx Group Inc, headquartered in Marietta, Georgia, stands as a pioneer and leader in placental biologics and therapeutic tissue manufacturing within the healthcare industry. Since 2008, the company has revolutionized advanced wound care by developing and distributing human placental tissue allografts through patent-protected processes. MiMedx specializes in transforming birth tissues including placenta, amniotic sac, and umbilical cord into life-saving medical solutions using their proprietary PURION process methodology, which employs aseptic processing techniques and terminal sterilization. The company manufactures innovative products including EPIEFFECT, a tri-layer human placental-based allograft containing over 300 regulatory proteins; AMNIOFIX for surgical applications including craniectomies; and AMNIOBURN for facial burn treatment. These biologics provide biocompatible human extracellular matrix that creates protective environments supporting natural healing processes. MiMedx serves healthcare professionals across plastic surgery, vascular surgery, orthopedic surgery, and wound care specialties. With accreditation from the American Association of Tissue Banks through 2027, MiMedx has supplied over two million allografts through direct and consignment shipments, addressing persistent wounds like diabetic foot ulcers, burns, and critical surgical applications. The company operates comprehensive reimbursement management solutions through MIMEDX Connect, positioning itself as a complete healthcare partner delivering measurable patient outcomes and reducing administrative burdens for medical providers nationwide.